Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Myocet + Cyclophosphamide + Metformin Vs Myocet + Cyclophosphamide in 1st Line Treatment of HER2 Neg. Metastatic Breast Cancer Patients

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
ClinicalTrials.gov · Datasets · License: Public Domain
Open Source ↗
human epidermal growth factor 2 negative carcinoma of breast
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 230357
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.